Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

P14.12.A IMMUNOTHERAPEUTIC ADVANCES IN GLIOMA MANAGEMENT: THE RISE OF VACCINE-BASED APPROACHES

2024Neuro-OncologyJournalOpen access

10.1093/neuonc/noae144.263 Full text1 citations

Authors

13 authors across 11 institutions in 6 countries.

M ShahFirst author
Wireko Andrew Awuah
as printed: W Awuah
J Tan
S Ranganathan
Kwadwo Darko
- Korle Bu Teaching Hospital (GH)
as printed: K Darko
Pearl Ohenewaa Tenkorang
- University of Ghana (GH)
as printed: P Ohenewaa Tenkorang
Bryan Badayelba Adageba
- Kwame Nkrumah University of Science and Technology (GH)
as printed: B Adageba
A Ahluwalia
Vallabh Shet
as printed: V Shet
Mrinmoy Kundu
as printed: M Kundu
Nicholas Aderinto
- Ladoke Akintola University of Technology (NG)
as printed: N Aderinto
Toufik Abdul-Rahman
as printed: T Abdul-Rahman
Oday AtallahSenior author
as printed: O Atallah

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Immunotherapy and Immune Responseslevel 3 · 0.98
Glioma Diagnosis and Treatmentlevel 3 · 0.96
Cancer Research and Treatmentslevel 3 · 0.96

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2024 · Neuro-Oncology · 1 citations
https://openalex.org/W4403510844

P14.12.A IMMUNOTHERAPEUTIC ADVANCES IN GLIOMA MANAGEMENT: THE RISE OF VACCINE-BASED APPROACHES · Sankore